190138-00-2 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 8-aminoquinoline-3-carboxylate is used as a chemical intermediate for the synthesis of various drugs and pharmaceutical products. Its unique structure and reactivity contribute to the development of new pharmaceuticals, enhancing the treatment options for a range of diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, ethyl 8-aminoquinoline-3-carboxylate is utilized for its potential antimalarial and anticancer properties. Its structure allows for the exploration of new drug candidates and the advancement of therapeutic strategies against these diseases.
Used in Drug Development:
Ethyl 8-aminoquinoline-3-carboxylate is employed in the development of new pharmaceuticals, leveraging its potential to contribute to the treatment of various diseases. Its diverse applications in drug synthesis and medicinal chemistry research make it a valuable compound in the pursuit of innovative therapeutic solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 190138-00-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,1,3 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 190138-00:
(8*1)+(7*9)+(6*0)+(5*1)+(4*3)+(3*8)+(2*0)+(1*0)=112
112 % 10 = 2
So 190138-00-2 is a valid CAS Registry Number.
190138-00-2Relevant academic research and scientific papers
Phenanthroline derivatives
-
, (2008/06/13)
The present invention provides a phenanthroline derivative of formula (I) wherein, for example, R1is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-(2-4C)alkoxycar
QUINOLINE COMPOUNDS AS H+-ATPASES
-
, (2008/06/13)
This invention relates to a quinoline compound of the formula: wherein R1 is a pyridyl group or aryl, each of which may be substituted with suitable substituent(s), A -COHN-or -NHCO-, n is an integer of 0 or 1, and is a group of the formula: In which R2, R3, R4, R5, R6 and R7 are as defined, and pharmaceutically acceptable salt thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prevention and/or the treatment of bone diseases caused by abnormal bone metabolism in human being or animals.
Phenanthroline derivatives
-
, (2008/06/13)
The present invention provides a phenanthroline derivative of formula (I) STR1 wherein, for example, R1 is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-(2-4C)alk
